A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)
Clinical trial NCT00836498 · TERMINATED
Trial details
- NCT number
- NCT00836498
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2010-01-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.